3 Magnificent Stocks That Could Double or More by 2030

Does a 100% return in less than seven years sound pretty good? Most investors would probably say so. But which stocks are good candidates to achieve such a gain?

Three Motley Fool contributors think they've found magnificent stocks that could double or more by 2030. Here's why they picked CRISPR Therapeutics (NASDAQ: CRSP), Eli Lilly (NYSE: LLY), and Viking Therapeutics (NASDAQ: VKTX).

David Jagielski (CRISPR Therapeutics): A promising stock that has a lot of runway for future growth is CRISPR Therapeutics. Its market cap is around $5.1 billion today, but it's not hard to see how it could surge to more than $10 billion by the start of the next decade.

Source Fool.com